Hematological Ratios Are Associated with Acute Kidney Injury and Mortality in Patients That Present with Suspected Infection at the Emergency Department.
Titus A P de HondGurbey OcakLeonie GroenewegJan Jelrik OosterheertSaskia HaitjemaMeriem KhairounKarin A H KaasjagerPublished in: Journal of clinical medicine (2022)
The early recognition of acute kidney injury (AKI) is essential to improve outcomes and prevent complications such as chronic kidney disease, the need for renal-replacement therapy, and an increased length of hospital stay. Increasing evidence shows that inflammation plays an important role in the pathophysiology of AKI and mortality. Several inflammatory hematological ratios can be used to measure systemic inflammation. Therefore, the association between these ratios and outcomes (AKI and mortality) in patients suspected of having an infection at the emergency department was investigated. Data from the SPACE cohort were used. Cox regression was performed to investigate the association between seven hematological ratios and outcomes. A total of 1889 patients were included, of which 160 (8.5%) patients developed AKI and 102 (5.4%) died in <30 days. The Cox proportional-hazards model revealed that the neutrophil-to-lymphocyte ratio (NLR), segmented-neutrophil-to-monocyte ratio (SMR), and neutrophil-lymphocyte-platelet ratio (NLPR) are independently associated with AKI <30 days after emergency-department presentation. Additionally, the NLR, SMR and NLPR were associated with 30-day all-cause mortality. These findings are an important step forward for the early recognition of AKI. The use of these markers might enable emergency-department physicians to recognize and treat AKI in an early phase to potentially prevent complications.
Keyphrases
- acute kidney injury
- emergency department
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- cardiac surgery
- peritoneal dialysis
- oxidative stress
- healthcare
- prognostic factors
- type diabetes
- risk factors
- endothelial cells
- cardiovascular disease
- immune response
- skeletal muscle
- adverse drug
- insulin resistance
- coronary artery disease
- case report
- single molecule
- electronic health record
- weight loss